Article

B+L launches peroxide-based lens solution

Bausch + Lomb has introduced a new peroxide cleaning and disinfecting solution, PeroxiClear 3%.

 

Bridgewater, NJ-Bausch + Lomb has introduced a new peroxide cleaning and disinfecting solution, PeroxiClear 3%.

The new solution offers an alternative peroxide-based product, and has been proven to keep contact lenses cleaner and moister for longer, according to the company.

“We’ve been hearing from many doctors that there’s been an increasing need to address their patients’ contact lens discomfort,” said Josephy Barr, OD, MS, FAAP, vice president, medical affairs, pharmaceuticals and vision care, Bausch  + Lomb. “(The company) is proud to now provide an alternative option and innovation with (this solution).

“Bausch + Lomb’s mission has always been to help patients see better to live better, and with the introduction of (this) cleaning and disinfecting solution, we can now offer them the most advanced peroxide-based lens solution on the market today,” Barr continued.

The solution will be available in major retailers starting in April and May, including Target, Rite-Aid, K-Mart, Walmart, Walgreens, and CVS. It will be available at most retailers nationwide by June.

The solution was also presented during SECO last week, and will again be shown during Vision Expo East next week in New York City.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.